Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.
出版信息
Br Heart J. 1980 Dec;44(6):672-3. doi: 10.1136/hrt.44.6.672.
Abstract
摘要
相似文献
1
Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.世界卫生组织/国际心脏和肺移植学会心肌病定义和分类特别工作组报告
Br Heart J. 1980 Dec;44(6):672-3. doi: 10.1136/hrt.44.6.672.
2
[Classification of cardiomyopathy].[心肌病的分类]
Masui. 2014 Jan;63(1):5-15.
3
[Definition and classification of cardiomyopathies and specific cardiomyopathies].[心肌病及特定心肌病的定义与分类]
Nihon Rinsho. 2000 Jan;58(1):7-11.
4
New WHO/ISFC classification of cardiomyopathies: a task not completed.世界卫生组织/国际心脏病学会联合会心肌病新分类法：一项未完成的任务。
Circulation. 1997 Sep 16;96(6):2081-2.
5
The cardiomyopathies, a review for the primary physician.心肌病：给基层医生的综述
P R Health Sci J. 2004 Dec;23(4):285-92.
6
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.1995年世界卫生组织/国际心脏病学会和联合会心肌病定义与分类专题小组报告
Circulation. 1996 Mar 1;93(5):841-2. doi: 10.1161/01.cir.93.5.841.
7
[Current knowledge of cardiomyopathy].[心肌病的当前知识]
Med Pregl. 1997 Nov-Dec;50(11-12):481-5.
8
[Cardiomyopathies. Definition and classification].
Med Trop (Mars). 1996;56(3 Suppl):31-2.
9
Definition and classification of the cardiomyopathies.
Pathol Microbiol (Basel). 1970;35(1):17-25. doi: 10.1159/000162194.
10
[Definition and classification of cardiomyopathies].
Bol Asoc Med P R. 1982 Apr;74(4):138-9.
引用本文的文献
1
Prevalence and Incidence of Dilated Cardiomyopathy in the United States and Western Europe: A Systematic Review.美国和西欧扩张型心肌病的患病率与发病率：一项系统评价
Cardiol Res. 2025 Jul 8;16(4):295-305. doi: 10.14740/cr2071. eCollection 2025 Aug.
2
Impact of SGLT-2 Inhibitors on Biomarkers of Heart Failure.钠-葡萄糖协同转运蛋白2（SGLT-2）抑制剂对心力衰竭生物标志物的影响
Cells. 2025 Jun 18;14(12):919. doi: 10.3390/cells14120919.
3
Systematic Review, Meta-Analysis, and Population Study to Determine the Biologic Sex Ratio in Dilated Cardiomyopathy.确定扩张型心肌病生物学性别比例的系统评价、荟萃分析和人群研究
Circulation. 2025 Feb 18;151(7):442-459. doi: 10.1161/CIRCULATIONAHA.124.070872. Epub 2025 Feb 3.
4
Stem cell therapy for non-ischemic dilated cardiomyopathy: a systematic review and meta-analysis.干细胞治疗非缺血性扩张型心肌病：系统评价和荟萃分析。
Syst Rev. 2024 Nov 8;13(1):276. doi: 10.1186/s13643-024-02701-2.
5
Twin Phenomena of Hypertrophic Cardiomyopathy: A Reported Case Series.肥厚型心肌病的双现象：病例系列报告。
Anatol J Cardiol. 2024 Nov;28(11):513-522. doi: 10.14744/AnatolJCardiol.2024.4653.
6
Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024.巴西心脏病学会和巴西放射学会心血管计算机断层扫描与磁共振成像指南 - 2024年
Arq Bras Cardiol. 2024 Oct 28;121(9):e20240608. doi: 10.36660/abc.20240608.
7
Storytelling of Hypertrophic Cardiomyopathy Discovery.肥厚型心肌病发现的故事讲述
J Cardiovasc Dev Dis. 2024 Sep 28;11(10):300. doi: 10.3390/jcdd11100300.
8
Mexican Registry of Cardiomyopathies: baseline data, diagnostic strategies, and treatment approaches in Mexico.墨西哥心肌病登记处：墨西哥的基线数据、诊断策略及治疗方法
Arch Cardiol Mex. 2024 Jul 29;95(1):18-25. doi: 10.24875/ACM.24000033.
9
Krüpple-like factors in cardiomyopathy: emerging player and therapeutic opportunities.心肌病中的Krüpple样因子：新兴角色与治疗机遇
Front Cardiovasc Med. 2024 Mar 7;11:1342173. doi: 10.3389/fcvm.2024.1342173. eCollection 2024.
10
Expanding roles of circRNAs in cardiovascular diseases.环状RNA在心血管疾病中的作用不断扩展。
Noncoding RNA Res. 2024 Feb 5;9(2):429-436. doi: 10.1016/j.ncrna.2024.02.001. eCollection 2024 Jun.
Zotero 插件